The right drug for the right patient at the right price

Applications derived from the Effect Model cover the full spectrum of the drug development lifecycle: research, clinical studies and market.

NOVADISCOVERY offers consulting services to pharmaceutical and biotechnology firms in clinical development and market access and partners with innovators in early-stage research.

Our offering centers on de-risking and demonstrating value with in silico clinical trials:

  • Identify/select therapeutic targets based on downstream clinical impact
  • Optimize trial design by characterizing responders
  • Demonstrate value by translating Phase 3 trial results into real-world outcomes and benchmarking against competitors
Predict drug efficacy long before clinical trials

In this section: